News

share

Opdivo (nivolumab) was turned down as a treatment for advanced bladder cancer, after being reviewed through the SMC’s...

share

Pracinostat is an oral histone deacetylase (HDAC) inhibitor that is currently under Phase III clinical trial in combination...

share

The partnership, coordinated by international health organisation PATH and funded by the Bill & Melinda Gates Foundation, will...

share

ADYNOVI is an extended half-life recombinant factor VIII (rFVIII) treatment indicated for on-demand and prophylactic use in haemophilia...

share

The breakthrough combines a biomaterial – a substance that has been engineered to interact with biological systems for...

share

Prescription cough and cold medication containing opioids such as codeine or hydrocodone will no longer be labelled as...

share

NBTXR3 is an aqueous suspension of hafnium oxide nanoparticles being developed for direct injection into cancerous tumours, and...

share

Vaccitech has raised £20 million in Series A financing in a round co-led by new investors GV (formerly...